tiprankstipranks
Trending News
More News >
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market

JCR Pharmaceuticals Co., Ltd. (4552) Ratios

Compare
1 Followers

JCR Pharmaceuticals Co., Ltd. Ratios

JP:4552's free cash flow for Q3 2025 was ¥0.71. For the 2025 fiscal year, JP:4552's free cash flow was decreased by ¥ and operating cash flow was ¥>-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.15 1.91 1.34 1.48 1.67
Quick Ratio
2.10 1.22 0.82 1.13 1.21
Cash Ratio
0.90 0.62 0.37 0.73 0.90
Solvency Ratio
0.43 0.19 0.14 0.36 0.25
Operating Cash Flow Ratio
0.45 0.31 -0.15 0.22 0.36
Short-Term Operating Cash Flow Coverage
1.08 1.04 -0.32 0.61 0.80
Net Current Asset Value
¥ 5.28B¥ 11.83B¥ 5.28B¥ 16.14B¥ 13.31B
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.23 0.24 0.19 0.25
Debt-to-Equity Ratio
0.19 0.41 0.44 0.36 0.47
Debt-to-Capital Ratio
0.16 0.29 0.30 0.26 0.32
Long-Term Debt-to-Capital Ratio
0.06 0.20 0.10 0.05 0.12
Financial Leverage Ratio
1.39 1.82 1.82 1.91 1.92
Debt Service Coverage Ratio
1.40 0.98 0.31 1.12 0.65
Interest Coverage Ratio
236.52 87.58 113.07 442.96 196.88
Debt to Market Cap
0.03 0.22 0.13 0.06 0.04
Interest Debt Per Share
46.71 187.40 183.77 146.66 146.88
Net Debt to EBITDA
1.37 0.43 1.37 -0.58 -0.80
Profitability Margins
Gross Profit Margin
71.65%72.90%74.13%79.52%74.03%
EBIT Margin
21.45%17.10%15.89%38.07%28.90%
EBITDA Margin
27.25%24.56%20.31%42.83%33.84%
Operating Profit Margin
21.45%17.57%14.49%39.02%27.49%
Pretax Profit Margin
21.28%16.90%15.76%37.99%28.76%
Net Profit Margin
16.04%12.85%10.98%28.40%22.91%
Continuous Operations Profit Margin
16.02%12.92%11.03%28.42%22.90%
Net Income Per EBT
75.39%76.02%69.70%74.76%79.65%
EBT Per EBIT
99.21%96.18%108.78%97.35%104.64%
Return on Assets (ROA)
3.97%5.39%3.97%14.94%9.34%
Return on Equity (ROE)
7.23%9.80%7.23%28.51%17.96%
Return on Capital Employed (ROCE)
8.41%10.45%8.41%36.19%18.48%
Return on Invested Capital (ROIC)
4.55%7.11%4.55%21.24%11.43%
Return on Tangible Assets
4.13%5.58%4.13%15.40%9.77%
Earnings Yield
2.15%5.25%2.15%5.20%1.56%
Efficiency Ratios
Receivables Turnover
2.62 2.87 3.08 3.28 3.68
Payables Turnover
11.21 13.06 5.69 7.90 2.66
Inventory Turnover
0.72 0.56 0.48 0.71 0.58
Fixed Asset Turnover
2.09 1.43 1.05 1.91 1.75
Asset Turnover
0.54 0.42 0.36 0.53 0.41
Working Capital Turnover Ratio
1.33 2.17 2.13 2.58 1.61
Cash Conversion Cycle
814.64 756.72 814.64 575.84 595.57
Days of Sales Outstanding
118.36 127.15 118.36 111.36 99.28
Days of Inventory Outstanding
760.48 657.53 760.48 510.67 633.28
Days of Payables Outstanding
64.20 27.96 64.20 46.20 136.99
Operating Cycle
878.84 784.68 878.84 622.03 732.56
Cash Flow Ratios
Operating Cash Flow Per Share
31.71 74.62 -44.25 75.08 83.72
Free Cash Flow Per Share
24.44 57.83 -113.11 -16.52 22.78
CapEx Per Share
7.27 16.79 68.86 91.60 60.94
Free Cash Flow to Operating Cash Flow
0.77 0.78 2.56 -0.22 0.27
Dividend Paid and CapEx Coverage Ratio
2.26 2.03 -0.49 0.69 1.20
Capital Expenditure Coverage Ratio
4.36 4.44 -0.64 0.82 1.37
Operating Cash Flow Coverage Ratio
0.68 0.40 -0.24 0.51 0.57
Operating Cash Flow to Sales Ratio
0.17 0.22 -0.16 0.18 0.34
Free Cash Flow Yield
-8.00%6.88%-8.00%-0.73%0.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
52.37 19.03 46.57 19.25 64.25
Price-to-Sales (P/S) Ratio
8.40 2.45 5.11 5.47 14.72
Price-to-Book (P/B) Ratio
6.34 1.87 3.37 5.49 11.54
Price-to-Free Cash Flow (P/FCF) Ratio
64.64 14.52 -12.49 -136.61 157.36
Price-to-Operating Cash Flow Ratio
49.82 11.26 -31.94 30.06 42.82
Price-to-Earnings Growth (PEG) Ratio
2.35 0.42 -0.63 0.17 0.41
Price-to-Fair Value
6.34 1.87 3.37 5.49 11.54
Enterprise Value Multiple
30.49 10.39 26.55 12.18 42.69
Enterprise Value
185.17B 109.37B 185.17B 266.60B 434.65B
EV to EBITDA
26.55 10.39 26.55 12.18 42.69
EV to Sales
5.39 2.55 5.39 5.22 14.45
EV to Free Cash Flow
-13.17 15.15 -13.17 -130.43 154.46
EV to Operating Cash Flow
-33.67 11.74 -33.67 28.70 42.03
Tangible Book Value Per Share
249.81 424.54 392.25 388.99 285.96
Shareholders’ Equity Per Share
249.17 450.18 419.61 411.26 310.72
Tax and Other Ratios
Effective Tax Rate
0.25 0.24 0.30 0.25 0.20
Revenue Per Share
188.08 343.54 276.27 412.88 243.57
Net Income Per Share
30.17 44.13 30.34 117.26 55.80
Tax Burden
0.70 0.76 0.70 0.75 0.80
Interest Burden
0.99 0.99 0.99 1.00 1.00
Research & Development to Revenue
0.26 0.26 0.26 0.14 0.18
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
-1.02 1.69 -1.02 0.48 1.20
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis